Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study

Institut de Cancérologie de la Loire27 sites in 1 country3,032 target enrollmentJune 2010

ConditionsCancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Cancer
Sponsor: Institut de Cancérologie de la Loire
Enrollment: 3032
Locations: 27
Primary Endpoint: Thromboembolic complications:
Status: Completed
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to identify risk factors for thromboembolic and /or infectious complications in 3,000 patients with solid tumor and receiving a Percutaneous Central Venous Catheter (PCVC). A better understanding of the risk factors for these complications in this population would then allow interventional studies to be proposed to assess the benefit of prophylactic procedures in a sub-group of patients at most risk.

Registry

clinicaltrials.gov

Start Date

June 2010

End Date

March 2015

Last Updated

9 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Institut de Cancérologie de la Loire

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patient with a neoplastic solid tumour with an indication for insertion of a PCVC.

Exclusion Criteria

•Haematological neoplasm pathology, PCVC removal scheduled within 2 weeks of insertion,
•Therapeutic doses of anticoagulants required at inclusion,
•PCVC inserted by the femoral vein